|
TMEM87A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.186000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.876600E-03 |
| Normal-vs-Stage2 |
2.578000E-02 |
| Normal-vs-Stage3 |
7.221000E-01 |
| Normal-vs-Stage4 |
6.971400E-01 |
| Stage1-vs-Stage2 |
9.993400E-01 |
| Stage1-vs-Stage3 |
1.622870E-03 |
| Stage1-vs-Stage4 |
9.597600E-03 |
| Stage2-vs-Stage3 |
3.490200E-02 |
| Stage2-vs-Stage4 |
7.376200E-02 |
| Stage3-vs-Stage4 |
9.336400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.312400E-02 |
| Normal-vs-AfricanAmerican |
4.175800E-01 |
| Normal-vs-Asian |
4.799600E-01 |
| Caucasian-vs-AfricanAmerican |
3.576800E-01 |
| Caucasian-vs-Asian |
7.680200E-01 |
| AfricanAmerican-vs-Asian |
5.656200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.227700E-02 |
| Normal-vs-Female |
7.137700E-02 |
| Male-vs-Female |
6.841800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.181000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.375750E-02 |
| Normal-vs-Age(61-80Yrs) |
1.197200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.686400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.162600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.436600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.510600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.818820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.416600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.291200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.751000E-04 |
| Normal-vs-Grade 2 |
9.779700E-04 |
| Normal-vs-Grade 3 |
4.603200E-01 |
| Normal-vs-Grade 4 |
7.680600E-01 |
| Grade 1-vs-Grade 2 |
7.520100E-02 |
| Grade 1-vs-Grade 3 |
1.062990E-03 |
| Grade 1-vs-Grade 4 |
7.174400E-04 |
| Grade 2-vs-Grade 3 |
1.998140E-04 |
| Grade 2-vs-Grade 4 |
2.846100E-04 |
| Grade 3-vs-Grade 4 |
2.776400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.317920E-03 |
| Normal-vs-ccB subtype |
1.016620E-01 |
| ccA subtype-vs-ccB subtype |
8.131700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.746200E-02 |
| Normal-vs-N1 |
6.936000E-01 |
| N0-vs-N1 |
7.872600E-01 |
|
|
